SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus Network

Aventus Network is currently facing intense community discussion following a significant price decline and reports of trading disruptions on exchanges. While some participants express concerns about potential market instability, others are debating the project's long-term utility in decentralized infrastructure and enterprise-grade blockchain applications.

Pi Network is a social cryptocurrency and developer platform designed to make digital currency mining accessible to everyday people through mobile devices. The project aims to build a widely distributed currency that facilitates transactions for real-world goods and services rather than purely speculative trading. Its main value proposition is a mobile-first mining system that allows users to earn rewards on their phones without requiring specialized hardware, draining battery life, or using excessive data.  The network operates on the Stellar Consensus Protocol and a Federated Byzantine Agreement, which allows computers to reach agreement by trusting specific groups of other peers. Security is maintained through a global trust graph built from individual user groups called security circles where members vouch for each other. Users participate in four primary roles as pioneers, contributors, ambassadors, or nodes to ensure the network remains decentralized. This meritocratic distribution model rewards consistent engagement and network growth rather than financial wealth or technical power.  Founded by Dr. Nicolas Kokkalis and Dr. Chengdiao Fan, both of whom hold doctoral degrees from Stanford University, the project is managed by Social Chain Inc. The ecosystem includes a native wallet, a dedicated browser, and a platform for decentralized applications where the PI token is used for peer-to-peer exchange and transaction fees. Additionally, tokens can be used for purchasing goods in an internal marketplace, staking in a launchpad, or voluntary lockups that support market stability while boosting personal mining rates. The project has focused on organic community growth and does not list any external institutional investors in its documentation.

Pi Network

Pi Network is trending amid deep community division over long-standing concerns regarding token lockups, migration delays, and the project's long-term utility versus its history of ad-driven revenue. While proponents frame it as a foundational digital asset with upcoming ecosystem developments, critics frequently label the project a scam, citing the lack of major exchange listings and the frustration of users unable to access their balances.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma is seeing intense community focus as investors track its progress in scaling high-performance semiconductor technology for AI and optical infrastructure, specifically monitoring potential partnerships and CHIPS Act funding. Sentiment remains highly polarized between long-term bulls betting on disruptive tech and potential acquisition, and skeptical traders focused on current revenue execution.

iShares Trust - iShares Biotechnology ETF

iShares Biotechnology ETF

The iShares Biotechnology ETF (IBB) is experiencing heightened investor attention driven by a mix of institutional accumulation in select small-cap biotech names and broader optimism surrounding sector-wide M&A activity. Market participants are actively discussing strategic partnership potentials, clinical catalyst pipelines, and the rotation into healthcare as a defensive hedge against macroeconomic volatility.

Chip

Chip (CHIP) is experiencing significant volatility and social media attention as investors debate its potential as a real-world asset (RWA) play focused on GPU financing for AI infrastructure. While supporters highlight the protocol's active loan pipeline and utility as an alternative to speculative meme coins, critics caution against its high supply of locked tokens and aggressive short-selling, characterizing it as a pump-and-dump scheme.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

Internet Computer (ICP) is attracting significant attention as investors shift focus toward decentralized infrastructure projects capable of supporting AI-native applications and sovereign cloud services. Community members are actively debating the long-term utility of its on-chain hosting capabilities and the potential impact of tokenomic updates while expressing divided sentiment regarding the token's historical price volatility.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is trending as market speculation intensifies over a potential buyout, with investors analyzing the $160 per share deal from Fox Corporation. Community members are actively debating the merger's fairness, the strategic implications of the cash-and-stock structure, and whether a higher counterbid might emerge.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing increased investor attention as the community debates the impact of its recent quarterly performance and the long-term potential of the DefenCath pipeline. Traders are heavily focused on the company's ability to maintain institutional support and navigate the competitive landscape following the end of its previous reimbursement incentives.

Cash Cat

Cash Cat is facing intense scrutiny from the community, with many traders expressing frustration over high spread fees on Robinhood and recent price volatility. While some participants are actively accumulating the token as a high-risk bet on the Robinhood network ecosystem, others are dismissing it as an overhyped project struggling with sell pressure.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently a focal point for investors due to its highly anticipated clinical data readouts and upcoming investor presentations for its lead drug candidate, soquelitinib. The community is actively debating the stock's significant short interest and the potential for a short squeeze alongside institutional accumulation, while sentiments remain polarized between those betting on long-term platform value and those skeptical of the company's ability to maintain its cash runway.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
